Abstract
This paper reports part of the findings from a larger study reported earlier, the European study on epidemiology and the management of HCV in the haemodialysis population (1). Centres recruited to the larger study were monitored for a further one year observation period to measure and generate a deeper understanding of HCV sero-conversion. From 4724 patients who were studied at the baseline, in 68 centres, only 13 patients were found to have sero-converted. These sero-conversions occurred in 7 hospitals within 5 different countries. Possible routes of transmission and risk factors are described with respect to the individual centres and good practice recommendations based on current evidence presented.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Austria / epidemiology
-
Belgium / epidemiology
-
Benchmarking
-
Cross Infection / epidemiology*
-
Cross Infection / etiology
-
Cross Infection / therapy*
-
Cross Infection / transmission
-
Disinfection / organization & administration
-
Evidence-Based Medicine
-
Health Facility Size
-
Hemodialysis Units, Hospital / organization & administration
-
Hepatitis C / epidemiology*
-
Hepatitis C / etiology
-
Hepatitis C / therapy*
-
Hepatitis C / transmission
-
Humans
-
Infection Control / organization & administration*
-
Israel / epidemiology
-
Italy / epidemiology
-
Kidney Failure, Chronic / complications
-
Kidney Failure, Chronic / therapy
-
Organizational Policy
-
Population Surveillance
-
Practice Guidelines as Topic
-
Renal Dialysis / adverse effects*
-
Risk Factors
-
Switzerland / epidemiology
-
Total Quality Management / organization & administration